BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
900 results:

  • 1. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
    Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
    JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways.
    Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers.
    Kenney RT; Cini JK; Dexter S; DaFonseca M; Bingham J; Kuan I; Chawla SP; Polasek TM; Lickliter J; Ryan PJ
    Front Immunol; 2024; 15():1362775. PubMed ID: 38487528
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
    Ruan GJ; Zanwar S; Ravindran A; Schram S; Abeykoon JP; Hazim A; Young JR; Shah MV; Bennani NN; Jiang L; Morlote D; Rech KL; Goyal G; Go RS;
    Am J Hematol; 2024 May; 99(5):871-879. PubMed ID: 38409747
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial.
    Cho HJ; Yun KH; Shin SJ; Lee YH; Kim SH; Baek W; Han YD; Kim SK; Ryu HJ; Lee J; Cho I; Go H; Ko J; Jung I; Jeon MK; Rha SY; Kim HS
    Nat Commun; 2024 Jan; 15(1):685. PubMed ID: 38263321
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
    Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
    Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma.
    Hu EY; Bhagavatula SK; Shi A; Merriam P; Levesque VM; Shyn PB
    Abdom Radiol (NY); 2024 Apr; 49(4):1241-1247. PubMed ID: 38240859
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
    Rajdev L; Jackie Wang CC; Joshi H; Lensing S; Lee J; Ramos JC; Baiocchi R; Ratner L; Rubinstein PG; Ambinder R; Henry D; Streicher H; Little RF; Chiao E; Dittmer DP; Einstein MH; Cesarman E; Mitsuyasu R; Sparano JA;
    Cancer; 2024 Mar; 130(6):985-994. PubMed ID: 37962072
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.
    Villanueva G; Lowe J; Tentoni N; Taluja A; Villarroel M; Narváez CE; León SA; Valencia Libreros DL; Gonzalez Suárez N; Mikkelsen TS; Howard SC
    Pediatr Hematol Oncol; 2024; 41(2):135-149. PubMed ID: 37865916
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors.
    Olsen HE; Liu KX; Frazier AL; O'Neill AF; Janeway KA; DuBois SG; Shulman DS
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30652. PubMed ID: 37644664
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Landscape of Alterations from 1407 Ultra-Rare sarcomas from the AACR GENIE Database: Clinical Implications.
    Denu RA; Moyers JT; Gouda MA; Conley AP; Lazar AJ; Subbiah V
    Clin Cancer Res; 2023 Nov; 29(22):4669-4678. PubMed ID: 37643131
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma.
    Mallard HJ; Wan S; Nidhi P; Hanscom-Trofy YD; Mohapatra B; Woods NT; Lopez-Guerrero JA; Llombart-Bosch A; Machado I; Scotlandi K; Kreiling NF; Perry MC; Mirza S; Coulter DW; Band V; Band H; Ghosal G
    Mol Cancer Res; 2023 Nov; 21(11):1186-1204. PubMed ID: 37478161
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
    Ingham M; Allred JB; Chen L; Das B; Kochupurakkal B; Gano K; George S; Attia S; Burgess MA; Seetharam M; Boikos SA; Bui N; Chen JL; Close JL; Cote GM; Thaker PH; Ivy SP; Bose S; D'Andrea A; Marino-Enriquez A; Shapiro GI; Schwartz GK
    J Clin Oncol; 2023 Sep; 41(25):4154-4163. PubMed ID: 37467452
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study.
    Fang X; Zhong C; Weng S; Hu H; Wang J; Xiao Q; Wang J; Sun L; Xu D; Liao X; Dong C; Zhang S; Li J; Ding K; Yuan Y
    BMC Cancer; 2023 Jul; 23(1):676. PubMed ID: 37464378
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Automated Segmentation of Sacral Chordoma and Surrounding Muscles Using Deep Learning Ensemble.
    Boussioux L; Ma Y; Thomas NK; Bertsimas D; Shusharina N; Pursley J; Chen YL; DeLaney TF; Qian J; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):738-749. PubMed ID: 37451472
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
    Epeldegui M; Chang D; Lee J; Magpantay LI; Borok M; Bukuru A; Busakhala N; Godfrey C; Hosseinipour MC; Kang M; Kanyama C; Langat D; Mngqibisa R; Mwelase N; Nyirenda M; Samaneka W; Hoagland B; Campbell TB; Martínez-Maza O; Krown SE;
    J Acquir Immune Defic Syndr; 2023 Oct; 94(2):165-173. PubMed ID: 37368929
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exploring the interactions of antihistamine with retinoic acid receptor beta (RARB) by molecular dynamics simulations and genome-wide meta-analysis.
    Kim MJ; Kulkarni V; Goode MA; Sivesind TE
    J Mol Graph Model; 2023 Nov; 124():108539. PubMed ID: 37331258
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.
    Dorvil N; Rivera VR; Riviere C; Berman R; Severe P; Bang H; Lavoile K; Devieux JG; Faustin M; Saintyl G; Mendicuti MD; Pierre S; Apollon A; Dumond E; Forestal GPL; Rouzier V; Marcelin A; McNairy ML; Walsh KF; Dupnik K; Reif LK; Byrne AL; Bousleiman S; Orvis E; Joseph P; Cremieux PY; Pape JW; Koenig SP
    PLoS Med; 2023 Jun; 20(6):e1004246. PubMed ID: 37294843
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results.
    Brastianos PK; Kim AE; Giobbie-Hurder A; Lee EQ; Lin NU; Overmoyer B; Wen PY; Nayak L; Cohen JV; Dietrich J; Eichler A; Heist RS; Krop I; Lawrence D; Ligibel J; Tolaney S; Mayer E; Winer E; Bent B; de Sauvage MA; Ijad N; Larson JM; Marion B; Nason S; Murthy N; Ratcliff S; Summers EJ; Mahar M; Shih HA; Oh K; Cahill DP; Gerstner ER; Sullivan RJ
    Nat Med; 2023 Jul; 29(7):1728-1737. PubMed ID: 37268724
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Nigericin Induces Apoptosis in Primary Effusion Lymphoma Cells by Mitochondrial Membrane Hyperpolarization and β-Catenin Destabilization.
    Umeyama H; Shigemi Z; Baba Y; Hara N; Watanabe T; Fujimuro M
    Anticancer Res; 2023 Jun; 43(6):2455-2465. PubMed ID: 37247906
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 45.